DERMIRA
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. Dermira’s portfolio of five product candidates targets significant market opportunities. It was founded in 2010 and headquartered in Menlo Park, California.
DERMIRA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2010-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.dermira.com
Total Employee:
101+
Status:
Active
Contact:
(650) 421-7200
Email Addresses:
[email protected]
Total Funding:
599.3 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon IPv6 Google Maps Cloudflare Google Google Maps API Google Cloud Cloudflare SSL
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Dermira
Apple Tree Partners
Apple Tree Partners investment in Series C - Dermira
Sabby Capital
Sabby Capital investment in Series C - Dermira
UCB
UCB investment in Series C - Dermira
Canaan Partners
Canaan Partners investment in Series C - Dermira
New Enterprise Associates
New Enterprise Associates investment in Series C - Dermira
Rock Springs Capital
Rock Springs Capital investment in Series C - Dermira
Aisling Capital
Aisling Capital investment in Series C - Dermira
Bay City Capital
Bay City Capital investment in Series C - Dermira
Canaan Partners
Canaan Partners investment in Series B - Dermira
